Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV Academic Article 2021 uri icon

authors

  • GONZÁLEZ- CORDÓN A.
  • MASIA CANUTO, MARIA DEL MAR
  • GOMPELS M.
  • DE WITH S.
  • FLORENCE E.
  • ESSER S.
  • RAFFI F.
  • BEHRENS G.
  • POZNIAL A.
  • GATELL JM
  • MARTINEZ E.
  • ASSOUMOU L.
  • GUTIERREZ RODERO, FELIX
  • MOYLE G.
  • WATERS L
  • JOHNSON M.
  • DOMINGO P.
  • FOX J.
  • STELLBRINCK HJ
  • GUARALDI G

publication date

  • 2021